George A. Scangos, President and CEO at Vir Biotechnology, Inc. (VIR), sold 55,500 shares at $30.65 ($1.7M) on 2022-02-18, disclosed to the SEC on 2022-02-22.
Open-market sale of $1.7M VIR by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.93 | 10,024 | $320K | 18.5% |
| 2 | $31.93 | 10,024 | $320K | 18.5% |
| 3 | $30.65 | 17,726 | $543K | 31.5% |
| 4 | $30.65 | 17,726 | $543K | 31.5% |
| Total | $31.11 avg | 55,500 | $1.7M | 100% |
| Filing → |
| VIR | SELL | 2024-02-26 | $614K | — | Filing → |
| VIR | SELL | 2024-02-20 | $568K | — | Filing → |
| VIR | SELL | 2023-02-24 | $1.4M | — | Filing → |